New Guidelines for Medical Management of Kidney Stones
May 21, 2014
AUA 2014 - New Guidelines for the Medical Management of Kidney Stones
David S. Goldfarb, MD
NYU School of Medicine
Click HERE to read the full guidelines
Click HERE to view a related slide presentation created by the MMKS Guideline Panel
David Goldfarb, MD, FACP, FASN, is a Professor of Medicine and Physiology at New York University School of Medicine and Chief of Clinical Nephrology at NYU Langone Medical Center; Chief of Nephrology and Hemodialysis at the NY VAMC, and Director of the Kidney Stone Prevention Program in the Endourology Section at Lenox Hill Hospital.
He graduated from Yale College in 1977 and Yale School of Medicine in 1981. He completed his residency training in internal medicine and his nephrology training at NYU/New York VA and is board certified in internal medicine and nephrology.
His research and clinical interests include kidney stones, chronic kidney disease (CKD), hypertension, uric acid, gout and many aspects of hemodialysis, including anemia and secondary hyperparathyroidism.
Dr. Goldfarb continues to teach renal physiology to NYU medical students and is the director of the nephrology section of the pathophysiology course. He is currently an associate editor and journal club editor of the Clinical Journal of the American Society of Nephrology and on the editorial board of Kidney International. He is the PI of the Cystinuria component of the NIDDK- and Office of Rare Diseases Research-funded Rare Kidney Stone Consortium.